Search Results - "Hefazi Torghabeh, Mehrdad" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients

Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients

by Gangat, Naseema, Karrar, Omer, Iftikhar, Moazah, McCullough, Kristen, Johnson, Isla M., Abdelmagid, Maymona, Abdallah, Mostafa, Al‐Kali, Aref, Alkhateeb, Hassan B., Begna, Kebede H., Mangaonkar, Abhishek, Saliba, Antoine N., Hefazi Torghabeh, Mehrdad, Litzow, Mark R., Hogan, William, Shah, Mithun, Patnaik, Mrinal M., Pardanani, Animesh, Badar, Talha, Murthy, Hemant, Foran, James, Palmer, Jeanne, Sproat, Lisa, Khera, Nandita, Arana Yi, Cecilia, Tefferi, Ayalew
Published in American journal of hematology (01.02.2024)

Get full text

Journal Article

Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival

Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival

by Karrar, Omer, Abdelmagid, Maymona, Rana, Masooma, Iftikhar, Moazah, McCullough, Kristen, Al‐Kali, Aref, Alkhateeb, Hassan B., Begna, Kebede H., Elliott, Michelle A., Mangaonkar, Abhishek, Saliba, Antoine, Hefazi Torghabeh, Mehrdad, Litzow, Mark R., Hogan, William, Shah, Mithun, Patnaik, Mrinal M., Pardanani, Animesh, Badar, Talha, Murthy, Hemant, Foran, James, Palmer, Jeanne, Sproat, Lisa, Khera, Nandita, Arana Yi, Cecilia, Tefferi, Ayalew, Gangat, Naseema
Published in American journal of hematology (01.02.2024)

Get full text

Journal Article

Pulmonary function and long-term survival in patients with PERDS after autologous hematopoietic stem cell transplantation

Pulmonary function and long-term survival in patients with PERDS after autologous hematopoietic stem cell transplantation

by Zhang, Zhenmei, Wieruszewski, Patrick M., Hefazi Torghabeh, Mehrdad, Hogan, William J., Yadav, Hemang
Published in Bone marrow transplantation (Basingstoke) (01.11.2023)

Get full text

Journal Article

Pulmonary function as a continuum of risk: critical care utilization and survival after allogeneic hematopoietic stem cell transplantation - a multicenter cohort study

Pulmonary function as a continuum of risk: critical care utilization and survival after allogeneic hematopoietic stem cell transplantation - a multicenter cohort study

by Yadav, Hemang, Herasevich, Svetlana, Zhang, Zhenmei, White, Bradley A., Hefazi Torghabeh, Mehrdad, Hogan, William J., Schulte, Philip J., Niven, Alexander S., Gajic, Ognjen
Published in Bone marrow transplantation (Basingstoke) (01.07.2024)

Get full text

Journal Article

Long-Term Pulmonary Function Trajectories After Allogeneic Bone Marrow Transplantation

Long-Term Pulmonary Function Trajectories After Allogeneic Bone Marrow Transplantation

by Yadav, Hemang, Torghabeh, Mehrdad Hefazi, Hogan, William J, Limper, Andrew H
Published in CHEST pulmonary (01.09.2023)

Get full text

Journal Article

Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia

Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia

by Gangat, Naseema, McCullough, Kristen, Abdelmagid, Maymona, Karrar, Omer, Powell, Marissa, Al-Kali, Aref, Alkhateeb, Hassan, Begna, Kebede, Mangaonkar, Abhishek, Saliba, Antoine, Torghabeh, Mehrdad Hefazi, Litzow, Mark, Hogan, William, Shah, Mithun, Patnaik, Mrinal, Pardanani, Animesh, Badar, Talha, Foran, James, Palmer, Jeanne, Sproat, Lisa, Yi, Cecilia Arana, Tefferi, Ayalew
Published in Haematologica (Roma) (01.01.2024)

Get full text

Journal Article

FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)( DEK::NUP214 ): The Mayo Clinic experience

FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)( DEK::NUP214 ): The Mayo Clinic experience

by Csizmar, Clifford M, Saliba, Antoine N, Greipp, Patricia T, Alkhateeb, Hassan, Begna, Kebede H, Foran, James M, Gangat, Naseema, Hogan, William J, Hook, C Christopher, Litzow, Mark R, Mangaonkar, Abhishek A, Palmer, Jeanne M, Pardanani, Animesh, Shah, Mithun V, Tefferi, Ayalew, Torghabeh, Mehrdad Hefazi, Wolanskyj-Spinner, Alexandra P, Patnaik, Mrinal M, Kaufmann, Scott H, Al-Kali, Aref
Published in Haematologica (Roma) (20.06.2024)

Get full text

Journal Article

Prognostic Significance of Early Declines in Pulmonary Function After Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Significance of Early Declines in Pulmonary Function After Allogeneic Hematopoietic Stem Cell Transplantation

by Yadav, Hemang, Torghabeh, Mehrdad Hefazi, Hogan, William J, Limper, Andrew H
Published in Respiratory care (01.10.2023)

Get full text

Journal Article

Characterisation and prognostic impact Of ZRSR2 mutations in myeloid neoplasms

Characterisation and prognostic impact Of ZRSR2 mutations in myeloid neoplasms

by Yacout, Mahmoud, Katamesh, Bahga, Jabban, Yazan, He, Rong, Viswanatha, David, Jevremovic, Dragan, Greipp, Patricia, Bessonen, Kurt, Palmer, Jeanne, Foran, James, Saliba, Antoine, Hefazi-Torghabeh, Mehrdad, Begna, Kebede, Hogan, William, Patnaik, Mrinal, Shah, Mithun, Alkhateeb, Hassan, Al-Kali, Aref
Published in Leukemia (23.09.2024)

Get full text

Journal Article

Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients

Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients

by Heybati, Kiyan, Ochal, Domenic, Hogan, William, Al-Khateeb, Hassan, Sklar, David, Herasevich, Svetlana, Litzow, Mark, Shah, Mithun, Torghabeh, Mehrdad Hefazi, Durani, Urshila, Bauer, Philippe, Gajic, Ognjen, Yadav, Hemang
Published in Annals of hematology (01.03.2024)

Get full text

Journal Article

Human CAR19 CD8 +iTreg exceed CAR19 CD8 CTLs both in suppressing GVHD lethality and eliminating CD19 +Nalm-6 lymphoma cells in vivo

Human CAR19 CD8 +iTreg exceed CAR19 CD8 CTLs both in suppressing GVHD lethality and eliminating CD19 +Nalm-6 lymphoma cells in vivo

by Larson, Jemma H, Compeer, Ewoud B, Torghabeh, Mehrdad Hefazi, Smith, Kyle D, Jin, Sujeong, Dougherty, Phillip, McDonald-Hyman, Cameron, Houle, Bailey, Dustin, Michael, Hippen, Keli L, Blazar, Bruce R
Published in The Journal of immunology (1950) (01.05.2023)

Get full text

Journal Article

EXTH-32. DEVELOPMENT OF EPHA3 DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME

EXTH-32. DEVELOPMENT OF EPHA3 DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME

by Ruff, Michael, Sakemura, Reona, Cox, Michelle, Hefazi Torghabeh, Mehrdad, Roman Moreno, Paulina, Schick, Kendall, Sarkaria, Jann, Kenderian, Saad
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)

Get full text

Journal Article

DDRE-18. DEVELOPMENT OF EGFRvIII AND EGFR DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME

DDRE-18. DEVELOPMENT OF EGFRvIII AND EGFR DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME

by Ruff, Michael, Sakemura, Reona, Manriquez-Roman, Claudia, Hefazi-Torghabeh, Mehrdad, Schick, Kendall, Michelle, Cox, Can, Ismail, Horvei, Paulina, Siegler, Elizabeth, Tapper, Erin, Kenderian, Saad
Published in Neuro-oncology (Charlottesville, Va.) (09.11.2020)

Get full text

Journal Article

Adjusting diffusing capacity for anemia in patients undergoing allogeneic HCT: a comparison of two methodologies

Adjusting diffusing capacity for anemia in patients undergoing allogeneic HCT: a comparison of two methodologies

by Yadav, Hemang, Torghabeh, Mehrdad Hefazi, Hoskote, Sumedh S, Pennington, Kelly M, Lim, Kaiser G, Scanlon, Paul D, Niven, Alexander S, Hogan, William J
Published in Current research in translational medicine (01.06.2024)

Get full text

Journal Article

Non-internal tandem duplication (ITD), non-tyrosine kinase domain (TKD) FLT3 mutations in myeloid malignancies: A brief report of 10 patients

Non-internal tandem duplication (ITD), non-tyrosine kinase domain (TKD) FLT3 mutations in myeloid malignancies: A brief report of 10 patients

by Higgins, Alexandra, Mangaonkar, Abhishek A., Hefazi, Mehrdad, Viswanatha, David, Horna, Pedro, Foran, James, Gangat, Naseema
Published in Leukemia research (01.09.2018)

Get full text

Journal Article

Early CMV Infection Detected By Quantitative Nucleic Acid Testing (QNAT) Is Associated with Lower Risk of Relapse after Reduced Intensity, but Not Myeloablative, Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Early CMV Infection Detected By Quantitative Nucleic Acid Testing (QNAT) Is Associated with Lower Risk of Relapse after Reduced Intensity, but Not Myeloablative, Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

by Hefazi Torghabeh, Mehrdad, Damlaj, Moussab, Alkhateeb, Hassan B, Razonable, Raymund, Al-Kali, Aref, Hashmi, Shahrukh K., Hogan, William J, Litzow, Mark R, Patnaik, Mrinal M
Published in Blood (03.12.2015)

Get full text

Journal Article

Coronary Artery Calcium As a Predictor of Non-Relapse Mortality and Overall Survival in Patients Undergoing Post-Transplant Cyclophosphamide As Gvhd Prophylaxis

Coronary Artery Calcium As a Predictor of Non-Relapse Mortality and Overall Survival in Patients Undergoing Post-Transplant Cyclophosphamide As Gvhd Prophylaxis

by Graham, Christopher D, Baranwal, Anmol, Ayala, Ernesto, Kharfan-Dabaja, Mohamed A., Roy, Vivek, Foran, James, Langer, Kimberly J., Murthy, Hemant, Iqbal, Madiha, Sproat, Lisa Z, Chhabra, Saurabh, Khera, Nandita, Durani, Urshila, Torghabeh, Mehrdad Hefazi, Mangaonkar, Abhishek, Shah, Mithun V., Litzow, Mark R., Hogan, William J., Ayoub, Chadi, Larsen, Carolyn, Alkhateeb, Hassan B.
Published in Transplantation and cellular therapy (01.02.2024)

Get full text

Journal Article

NPM1+/FLT3- Patients with Acute Myeloid Leukemia (AML) Have Excellent Clinical Outcome Independent of Age When Treated with Cytotoxic Chemotherapy: Mayo Clinic Experience

NPM1+/FLT3- Patients with Acute Myeloid Leukemia (AML) Have Excellent Clinical Outcome Independent of Age When Treated with Cytotoxic Chemotherapy: Mayo Clinic Experience

by Hefazi Torghabeh, Mehrdad, Siddiqui, Mustaqeem A, Patnaik, Mrinal M., Wolanskyj, Alexandra, Zblewski, Darci, Elliott, Michelle, Hogan, William J, Litzow, Mark R., Al-Kali, Aref
Published in Blood (06.12.2014)

Get full text

Journal Article

METHODS AND MATERIALS FOR TREATING GRAFT-VERSUS-HOST DISEASE

METHODS AND MATERIALS FOR TREATING GRAFT-VERSUS-HOST DISEASE

by TORGHABEH, Mehrdad Hefazi, KENDERIAN, Saad J
Year of Publication 19.01.2022

Get full text

Patent

METHODS AND MATERIALS FOR TREATING GRAFT-VERSUS-HOST DISEASE

METHODS AND MATERIALS FOR TREATING GRAFT-VERSUS-HOST DISEASE

by Torghabeh, Mehrdad Hefazi, Kenderian, Saad J
Year of Publication 20.05.2021

Get full text

Patent